Return to program book search
Vasculitis and Vasculopathy: An Update
Sunday, March 23
3:30 PM - 5:30 PM
Lyn M. Duncan, MD
- Lynne J. Goldberg, MD, FAAD
- Rosalynn M. Nazarian, MD
Following this course, the attendee should be able to:
- Differentiate vasculopathy from vasculitis.
- Identify specific drug-related etiologies of vascular injury.
- Perform clinical pathological correlations using laboratory studies.
Prompt and accurate diagnosis of vascular injury has important clinical implications. The histopathological features of thrombotic vasculopathy and vasculitis in the skin will be described with an emphasis on clinical pathological correlation and the interpretation of laboratory results. Topics will include warfarin-induced skin necrosis, hypocomplementemic urticarial vasculitis, Remicade (infliximab)-induced vasculitis, cocaine/Levamisole-associated thrombotic vasculopathy, septic vasculitis and purpura fulminans.
|Sunday, March 23|
|3:30 PM||Clinical Features of Vasculitis and Vasculopathy / Dr. Goldberg|
|3:45 PM||Chemistry and Laboratory Findings in Vasculitis and Vasculopathy / Dr. Nazarian|
|4:00 PM||Histopathological Features of Vasculitis and Vasculopathy / Dr. Duncan|
|4:15 PM||Case Presentations / All faculty|
|5:15 PM||Q & A / All faculty|